HK1164708A1 - 種含有 值調節劑的紫杉烷類藥物溶液及其製備方法 - Google Patents

種含有 值調節劑的紫杉烷類藥物溶液及其製備方法

Info

Publication number
HK1164708A1
HK1164708A1 HK12105418.9A HK12105418A HK1164708A1 HK 1164708 A1 HK1164708 A1 HK 1164708A1 HK 12105418 A HK12105418 A HK 12105418A HK 1164708 A1 HK1164708 A1 HK 1164708A1
Authority
HK
Hong Kong
Prior art keywords
taxanes
regulator
preparation
pharmaceutical solution
pharmaceutical
Prior art date
Application number
HK12105418.9A
Other languages
English (en)
Inventor
陳建明
高保安
鄧莉
楊秋霞
孫靖
劉薇
顧芃
張瑩瑩
張佳良
Original Assignee
天士力控股集團有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43899845&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1164708(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 天士力控股集團有限公司 filed Critical 天士力控股集團有限公司
Publication of HK1164708A1 publication Critical patent/HK1164708A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK12105418.9A 2009-10-23 2012-06-04 種含有 值調節劑的紫杉烷類藥物溶液及其製備方法 HK1164708A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2009100709318A CN102038635A (zh) 2009-10-23 2009-10-23 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
PCT/CN2010/077996 WO2011047637A1 (zh) 2009-10-23 2010-10-22 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法

Publications (1)

Publication Number Publication Date
HK1164708A1 true HK1164708A1 (zh) 2012-09-28

Family

ID=43899845

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12105418.9A HK1164708A1 (zh) 2009-10-23 2012-06-04 種含有 值調節劑的紫杉烷類藥物溶液及其製備方法

Country Status (11)

Country Link
US (1) US9241922B2 (zh)
EP (1) EP2491919B2 (zh)
JP (1) JP5847722B2 (zh)
KR (1) KR101722398B1 (zh)
CN (2) CN102038635A (zh)
AR (1) AR078736A1 (zh)
AU (1) AU2010310258B2 (zh)
CA (1) CA2765748C (zh)
HK (1) HK1164708A1 (zh)
PL (1) PL2491919T5 (zh)
WO (1) WO2011047637A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009047794A2 (en) * 2007-10-01 2009-04-16 Intas Pharmaceuticals Limited Taxane derivative composition
CN109745287A (zh) 2010-05-03 2019-05-14 帝国制药美国公司 非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JP2013194009A (ja) * 2012-03-21 2013-09-30 Nipro Corp ドセタキセル製剤
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
JP6076744B2 (ja) * 2013-01-04 2017-02-08 ナガセ医薬品株式会社 ドセタキセル含有医薬組成物
JP6292267B2 (ja) * 2016-09-13 2018-03-14 ニプロ株式会社 ドセタキセル製剤
JP2018115178A (ja) * 2018-03-15 2018-07-26 ニプロ株式会社 ドセタキセル製剤
CN111153535B (zh) * 2020-01-19 2022-03-25 武汉市新华印刷有限责任公司 一种显影机冲版废水处理系统

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
JP2006501134A (ja) 2001-12-20 2006-01-12 ブリストル−マイヤーズ　スクイブ　カンパニー 高い生物学的利用能を有する、経口活性タキサン誘導体の医薬組成物
EP1558241A2 (en) 2002-11-08 2005-08-03 Bristol-Myers Squibb Company Pharmaceutical compositions and methods of using taxane derivatives
CN1535679A (zh) * 2003-04-04 2004-10-13 齐鲁制药厂 含有紫杉醇类物质的药物组合物及其制备方法
US20070202070A1 (en) * 2004-03-31 2007-08-30 Motoaki Kamachi Moisture Retention Polymer Compound
EP1799631B1 (en) * 2004-09-24 2017-01-25 Showa Denko K.K. Hydroxycitric acid derivatives and skin external preparations containing the same
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
EP1862183B1 (en) * 2005-03-14 2010-11-03 Otsuka Pharmaceutical Factory, Inc. Kit comprising drug and fat emulsion
JP2008543789A (ja) * 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー ドセタキセルの液体薬学的処方物
JP2007032374A (ja) 2005-07-25 2007-02-08 Usui Kokusai Sangyo Kaisha Ltd フューエルデリバリパイプ
CN101023940A (zh) * 2006-02-20 2007-08-29 郝守祝 一种紫杉烷类化合物的药用组合物、制备方法及用途
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
CN101244053B (zh) * 2007-02-16 2010-12-08 石药集团中奇制药技术（石家庄）有限公司 以多西他赛为主组分的新的分散体系
AU2008269179A1 (en) * 2007-06-22 2008-12-31 Scidose Llc Solubilized formulation of docetaxel without Tween 80
WO2009047794A2 (en) * 2007-10-01 2009-04-16 Intas Pharmaceuticals Limited Taxane derivative composition
CN101288642B (zh) * 2007-11-07 2011-04-27 天津天士力集团有限公司 一种紫杉烷类药物静脉给药制剂及其制备方法
AU2008346121B2 (en) * 2007-12-24 2013-10-10 Sun Pharma Advanced Research Company Limited Nanodispersion

Also Published As

Publication number Publication date
CA2765748C (en) 2016-10-25
AU2010310258B2 (en) 2013-09-19
KR20120087902A (ko) 2012-08-07
PL2491919T3 (pl) 2017-08-31
EP2491919A4 (en) 2013-09-18
KR101722398B1 (ko) 2017-05-17
AR078736A1 (es) 2011-11-30
PL2491919T5 (pl) 2019-12-31
CA2765748A1 (en) 2011-04-28
JP5847722B2 (ja) 2016-01-27
JP2013508312A (ja) 2013-03-07
EP2491919B2 (en) 2019-06-26
WO2011047637A1 (zh) 2011-04-28
CN102448441A (zh) 2012-05-09
US9241922B2 (en) 2016-01-26
EP2491919B1 (en) 2016-05-11
CN102038635A (zh) 2011-05-04
AU2010310258A1 (en) 2012-01-19
CN102448441B (zh) 2014-09-17
US20120157517A1 (en) 2012-06-21
EP2491919A1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
HK1164708A1 (zh) 種含有 值調節劑的紫杉烷類藥物溶液及其製備方法
HK1250313A1 (zh) 穩定的藥物組合物和使用所述組合物的方法
HK1154502A1 (zh) 製備載藥乳劑的方法
EP2623579A4 (en) HYDROPHOBIC RETENTION AGENT AND PREPARATION METHOD THEREOF
HK1175129A1 (zh) 給藥裝置和組裝方法
IL217292A0 (en) Polypeptides and method of treatment
GB201302653D0 (en) Pharmaceutical compositions and methods of treatment
EP2435935A4 (en) METHOD OF PROVIDING A POSTCARD PATENT CARD AND SYSTEM THEREOF
IL197655A0 (en) Emulsions and methods of their production
EP2396763A4 (en) METHOD FOR PROVIDING A GAME AND SYSTEM THEREFOR
HRP20181979T1 (hr) Medicinsko ljepilo i postupak njegove proizvodnje
EP2497625A4 (en) CYLINDER STRUCTURE AND MANUFACTURING METHOD THEREFOR
EP2394979A4 (en) INTERMEDIATE OF CILASTATIN AND METHOD FOR PREPARING THE SAME
ZA201109514B (en) Method of drug delivery
ZA201203060B (en) Composition and method of delivery
GB2488494B (en) Solution, use and method of preparation thereof
PL2569168T3 (pl) Wkładka informacyjna leku i sposób jej wytwarzania
EP2726192A4 (en) METHOD OF ENCAPSULATION AND IMMOBILIZATION
PL387415A1 (pl) Kompozycja farmaceutyczna zawierająca celekoksyb oraz sposób jej wytwarzania
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
GB201004835D0 (en) Comsumables and method of production thereof
GB201004833D0 (en) Comsumables and method of production thereof
ZA201200077B (en) Polypeptides and method of treatment
PL388223A1 (pl) Kompozycja farmaceutyczna zasady zyprazydonu oraz sposób jej wytwarzania

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211024